Insmed Inc (NASDAQ: INSM)’s stock price has surge by 2.90relation to previous closing price of 98.73. Nevertheless, the company has seen a 43.73% surge in its stock price over the last five trading sessions. forbes.com reported 2025-06-16 that Insmed Inc (NASDAQ: INSM) was nothing short of a powerhouse last month, soaring 45%, while the S&P 500 index rose 3% in the same timeframe. What’s driving this surge?
Is It Worth Investing in Insmed Inc (NASDAQ: INSM) Right Now?
The 36-month beta value for INSM is at 0.79. Analysts have varying views on the stock, with 14 analysts rating it as a “buy,” 6 rating it as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for INSM is 178.06M, and currently, shorts hold a 9.81% of that float. The average trading volume for INSM on June 17, 2025 was 2.82M shares.
INSM’s Market Performance
The stock of Insmed Inc (INSM) has seen a 43.73% increase in the past week, with a 51.13% rise in the past month, and a 30.63% gain in the past quarter. The volatility ratio for the week is 3.56%, and the volatility levels for the past 30 days are at 6.07% for INSM. The simple moving average for the last 20 days is 32.71% for INSM stock, with a simple moving average of 38.13% for the last 200 days.
Analysts’ Opinion of INSM
Many brokerage firms have already submitted their reports for INSM stocks, with Jefferies repeating the rating for INSM by listing it as a “Buy.” The predicted price for INSM in the upcoming period, according to Jefferies is $105 based on the research report published on May 13, 2025 of the current year 2025.
RBC Capital Mkts, on the other hand, stated in their research note that they expect to see INSM reach a price target of $100. The rating they have provided for INSM stocks is “Outperform” according to the report published on February 25th, 2025.
Truist gave a rating of “Buy” to INSM, setting the target price at $48 in the report published on April 23rd of the previous year.
INSM Trading at 41.04% from the 50-Day Moving Average
After a stumble in the market that brought INSM to its low price for the period of the last 52 weeks, the company was able to rebound, for now settling with 1.59% of gains for the given period.
Insider Trading
Reports are indicating that there were more than several insider trading activities at INSM starting from Lewis William, who proposed sale 135,009 shares at the price of $100.36 back on Jun 16 ’25. After this action, Lewis William now owns shares of Insmed Inc, valued at $13,549,587 using the latest closing price.
Adsett Roger, the Officer of Insmed Inc, proposed sale 10,686 shares at $98.79 during a trade that took place back on Jun 16 ’25, which means that Adsett Roger is holding shares at $1,055,688 based on the most recent closing price.
Stock Fundamentals for INSM
Current profitability levels for the company are sitting at:
- -2.3 for the present operating margin
- 0.76 for the gross margin
The net margin for Insmed Inc stands at -2.66. The total capital return value is set at -0.56. Equity return is now at value -890.75, with -68.42 for asset returns.
Based on Insmed Inc (INSM), the company’s capital structure generated 0.92 points at debt to capital in total, while cash flow to debt ratio is standing at -0.67. The debt to equity ratio resting at 11.53. The interest coverage ratio of the stock is -10.72.
Currently, EBITDA for the company is -814.14 million with net debt to EBITDA at -0.8. When we switch over and look at the enterprise to sales, we see a ratio of 50.5. The receivables turnover for the company is 7.98for trailing twelve months and the total asset turnover is 0.21. The liquidity ratio also appears to be rather interesting for investors as it stands at 5.86.
Conclusion
In conclusion, Insmed Inc (INSM) has had a better performance lately. Opinion on the stock among analysts is bullish, with some giving it a “buy” rating and others a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
